Researchers seem to have discovered a new way to manage diabetes without using needles or any other invasive means. The University of Iowa team found that when diabetic mice were exposed to a combination of magnetic fields and static electricity fields for a few hours on a daily basis, it caused them to have normal insulin and blood sugar levels. This unexpected discovery opens the door to a novel way of managing diabetes in humans more easily and safely.
According to the findings which appeared in the journal Cell Metabolism on October 6, the initial discovery which led to this research was purely accidental. Sunny Huang, one of the researchers on this study, needed to practice how to draw blood from mice and measure the blood glucose levels of the samples taken. Calvin Carter, PhD, the co-lead author, give Sunny several rodents which he had been doing research on regarding how electromagnetic fields affect the behavior and brains of mice.
Sunny was astounded to find that all the mice had normal blood glucose and insulin levels and yet mice exposed to EMF tended to have high blood pressure and diabetes. What was more shocking was the fact that these particular mice had been genetically modified so that they could all be diabetic.
When Carter’s attention was drawn to this anomaly, a partnership was born to study how EMFs could be used to treat or even reverse diabetics. The researchers felt that if they investigated the matter further and confirmed that electromagnetic fields and static electricity could indeed reverse the biomarkers for diabetes, then a major way to handle diabetic patients would have been opened. The results held up.
The researchers say that there are indicators everywhere that some cells in the body are uniquely designed to respond to electromagnetic radiation. For example, migratory birds are said to rely on EMFs for navigation.
The team found that an oxidant molecule called superoxide in the liver of mice was responsible for the activation of an antioxidant body response which rebalanced the body’s ability to react to insulin and control blood sugar levels.
When the researchers removed those superoxide molecules from the liver, they noticed that EMFs couldn’t have any effect on the insulin and blood glucose levels of the mice.
The team is now turning its attention to studying whether the beneficial effects of EMFs on diabetes can also be replicated in humans. If that turns out to be the case, the researchers hope to develop therapies around their discovery. There are lots of biomedical companies out there striving day and night to come up with new ways to address the current health challenges. One interesting company which you can watch is DarioHealth Corp. (NASDAQ: DRIO). They focus on digital therapeutics and they have popularized smartphone-based software to manage chronic illnesses.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. A recent article discussing CNS Pharmaceuticals reads, “The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.”
CNS Pharmaceuticals is developing novel treatments for primary and metastatic cancers of the brain and central nervous system. Its lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. CNS holds a worldwide exclusive license to the Berubicin chemical compound and has acquired all data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase 1 clinical trial with Berubicin in malignant brain tumors, which Reata conducted in 2006. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. This 44% disease control rate was based on 11 patients (out of 25 evaluable patients) with stable disease, plus responders. One patient experienced a durable complete response and remains cancer-free as of February 20, 2020. These Phase 1 results represent a limited patient sample size and, while promising, are not a guarantee that similar results will be achieved in subsequent trials. By the end of 2020, CNS expects to commence a Phase 2 clinical trial of Berubicin for the treatment of GBM in the United States, while a sub-licensee partner undertakes a Phase 2 trial in adults and a first-ever Phase 1 trial in pediatric GBM patients in Poland. The company’s second drug candidate, WP1244, is a novel DNA binding agent that has shown in preclinical studies to be 500 times more potent than the chemotherapeutic agent daunorubicin in inhibiting tumor cell proliferation. For more information, visit the company’s website at www.CNSPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to CNSP are available in the company’s newsroom at http://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into agreements with six kindergartens in Xiamen to conduct “Augmented Reality Immersive Classes” (“ARIC”) for students. Xiamen, where Blue Hat is headquartered, has a population base of approximately 3.5 million. The company hopes to engage with over 50 kindergartens by the end of 2020. “We are so delighted to deploy our ARIC immersive software classes in six kindergartens in Xiamen,” BHAT CEO Xiaodong Chen said in the news release. “For several years, we have felt that the end applications of our AR interactive games and products can be utilized for both entertainment and educational purposes through the implementation of visual learning. In the future, the company will work with each cooperated kindergarten and work to improve and optimize our content for teaching purposes.”
Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile-game features. The company’s entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the company’s investor relations website at www.IR.BlueHatGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Cannabis legalization activists in Vermont can finally breathe a sigh of relief after the governor announced that he will allow legal marijuana sales to take place in the state without his signature. Although the state legalized personal possession of up to one ounce and cultivation of two plants in 2018, retail sales have been prohibited. Governor Phil Scott’s decision to allow legal sales will finally create a tax-and-regulate system for the industry. On top of that, he also signed separate legislation to automate expungements for prior cannabis convictions.
Before being reconciled in a bicameral conference committee last month, different versions of the marijuana sales proposal passed each chamber. After the finalized proposal was sent by the legislature to the governor, he was non-committal about his plans for the legislation up to the day before the signature deadline. Although he hinted that he was considering vetoing the bill, he ultimately decided to let the legislation pass.
Most of Gov. Scott’s issues with the proposal had to do with impaired driving, taxes, and local control. Before the finalized proposal was presented to him, the governor stated that while he appreciated the legislative process the bill had gone through, certain racial justice groups had raised concerns with his office about how the proposal addressed social equity in the cannabis industry for communities that had been most affected by prohibition.
Last Tuesday, he stated that lawmakers “did move forward in a lot of areas that I had concerns about, but it isn’t exactly what I’d like to see and there are some shortcomings.” But when the time came, he stood out of the way and let the legislation pass. “However, there is still more work to be done to ensure the health and safety of our kids and the safety of our roadways – we should heed the public health and safety lessons of tobacco,” Gov. Scott wrote in a letter to lawmakers announcing his decision.
“Further, I believe we are at a pivotal moment in our nation’s history which requires us to address systemic racism in our governmental institutions. We must take additional steps to ensure equity is a fundamental principle in a new market. The concerns with this bill of the communities historically most affected by cannabis enforcement were not meaningfully incorporated into this bill,” he says.
He argued that lawmakers should consider creating a social equity applicant category for cannabis licenses as well as a 50% licensing waiver for those applicants and additional technical and financial assistance. Despite the bill’s apparent shortcomings, it has been celebrated by cannabis reform activists.
“It’s a great relief to learn that Vermont will finally move forward with plans to replace prohibition with sensible regulation,” says Matt Simon, New England Political Director for the Marijuana Policy Project. “Legislators bent over backward to address Gov. Scott’s concerns throughout this process, and it’s now clear that these difficult compromises weren’t made in vain.”
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW420? Ask our Editor
Friday, October 16th, 2020UncategorizedComments Off on $WTER 420 with CNW – Vermont Governor Allows Marijuana Bill to be Operational Without His Signature
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announced that its wholly owned subsidiary, Mulch Manufacturing Inc., was awarded a one-year natural mulch supply contract with two additional one-year extensions with the city of Vero Beach, Florida. According to the update, the company secured the contract shortly after its receipt of a mulch contract from Circle K convenience store divisions. “We are pleased to be awarded this new government contract opportunity and it’s all thanks to our recently completed construction in the Waste Management facility in central Florida,” SGTM’s CEO and Director Tony Raynor said in the news release.
Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division and collection sites, then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential, and commercial clients. For information regarding SGTM’s operations, expansion plans and production facilities, visit http://nnw.fm/3iVHn
NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://nnw.fm/SGTM
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
SRAX (NASDAQ: SRAX), an innovative fintech solutions provider, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to provide specialized content distribution via widespread syndication channels. The episode features Christopher Miglino, founder and CEO of SRAX, and Chris Lahiji, president of LD Micro. During the program, the two executives discuss the recent acquisition of LD Micro, a leading data and event company serving the small and micro-cap space, by SRAX, a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire. SRAX announced closing of the acquisition on Sept. 16, 2020, noting that LD Micro will operate as a wholly owned subsidiary of SRAX and will continue to employ Lahiji, its founder, as its president. “If you look at what we’ve built at LD, we’ve had a lot of interest over the last 11 or 12 years in getting acquired, but the reality was that every single organization wanted to use the community that we had built for the wrong purposes,” Lahiji stated in the interview. “Christopher Miglino was the only guy who came to me and essentially asked the right questions and found a way of taking what we had built since 2002 and enhancing it. . . . With SRAX, I have the ability to increase my reach by more than 100-fold without having to sacrifice anything that has been built prior to [the acquisition]. The dynamics that they bring to the table for LD are incalculable.”
SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Sigma Labs (NASDAQ: SGLB), a leading developer of in-process, quality-assurance software for the commercial 3D-printing industry, has scheduled a conference call to discuss its third-quarter 2020 results. The call is scheduled for Thursday, Oct. 22, 2020, at 4:30 p.m. ET. The call will be hosted by Sigma Labs president and CEO Mark Ruport and CFO Frank Orzechowski, and will include an overview of the company’s performance covering the period ending Sept. 30, 2020. The two company executives will also participate in a Q&A session during the call. Those interested in accessing the call can dial in five to ten minutes prior to the call starting to register with an operator. Numbers are 1-877-407-9039 (toll free) in the United States or 1-201-689-8470 internationally; the conference ID for the call is 13711743. Those interested may also watch the broadcast live at https://nnw.fm/v7mJG or via the investor relations section of the company’s website at www.sigmalabsinc.com. In addition, the conference call will be available for replay through Nov. 5, 2020.
Sigma Labs is a leading provider of quality-assurance software to the commercial 3D-metal printing industry under the PrintRite3D(R) brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D for 3D-metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies in real time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.SigmaLabsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
A lot can be said about what should or shouldn’t have been done to stem the spread of the novel coronavirus across the U.S. at the beginning of this year, but the truth is that the U.S. has unique factors that have influenced the trajectory of this pandemic. We analyze some of those crucial driving factors.
A Large Population
The U.S. is undeniably the third most populous country in the world, and that huge population provides a large sample space for the virus to get willing or unwilling hosts. When global COVID-19 cases are analyzed, the most affected countries also double as those with the largest populations. For example, the U.S., Russia, India, Brazil and Mexico. China doesn’t qualify for inclusion here because its caseload statistics are questionable at best.
To illustrate this population factor even more, a look at the most affected U.S. states indicates that they are also the ones with the largest populations in the country. These include New York State, California, Texas, Florida and Illinois.
Country Size
The novel coronavirus disease can generally be described as a regional disease, with larger countries finding it harder to contain outbreaks since they can spring up from anywhere across the vast stretch of the country.
Globally, the U.S. is the fourth largest country in terms of land mass. It therefore isn’t surprising that the U.S. has been badly affected by this pandemic since a look at the other worst affected countries shows that they happen to command a large land mass as well. They include Brazil, India, Argentina and Russia.
Mobility Within and Out of the Country
It is a known fact that the coronavirus doesn’t move from one place to another on its own. Rather, it is spread by people who travel from one location to another. According to several sources, such as the Washington Post, the U.S. takes the first spot in terms of internal travel by its residents. It also ranks as the third in terms of receiving travelers from other parts of the world, and it follows closely behind Spain and France. France and Spain have also taken a severe beating from the virus, and so did other countries like Italy which receive a lot of foreign travelers.
Diversity of the Population
Pew Research suggests that there is a genetic factor to the spread (or lack thereof) of the COVID-19 pandemic, and estimates indicate that the U.S ranks high among countries with diverse populations.
Diversity means that some sections of the population will exhibit degrees of resistance to the virus, while others will be highly susceptible to the infection. Other socioeconomic factors can also come into play, and that could be why predominantly black communities in the U.S. had it rough, just as the elderly in nursing homes.
It may be a little unfair to say the U.S. has been disproportionately affected by the pandemic because it is hard to adjust for the factors above in each country across the world for a fair comparison. Biomedical industry watchers wonder what entities like Processa Pharmaceuticals Inc. (NASDAQ: PCSA) would suggest to avoid such a catastrophe in future.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
It is hard to believe that the medical supply shortages which manifested a few weeks into the COVID-19 pandemic persist and have gotten worse in some cases. Ventilators, PPE and testing reagents are just a few of the critically needed medical supplies that the U.S. appears to be unable to get hold of in sufficient quantities. But why is this so?
In 2004, the administration of the day created the Strategic National Stockpile (“SNS”) with the aim of having a safety net during short-term emergencies, such as terrorist attacks. While this entity wasn’t designed or even equipped to handle an emergency of the scale of this current pandemic, they nevertheless should have been in position to alleviate some of these existing challenges. But they didn’t or haven’t. A number of glaring inadequacies could explain why the SNS hasn’t been of much help during this crisis.
Limited Clout and Visibility
Over the years, the sense of urgency that prompted the creation of the SNS has dwindled and subsequent administrations have allowed the agency to slide downwards on the list of critically needed teams.
For example, funding for restocking vital supplies has been cut almost every fiscal year, and this has left the SNS with no muscle to act when it deems fit.
Furthermore, the lack of clout has meant that even if the SNS raises an alarm about a situation, their voices aren’t given the attention they deserve. A clear example are the repeated warnings of SNS experts about the risks of globally significant diseases which have been ignored, and the strategic plan of SNS hasn’t been renewed since 2017.
More clout and greater visibility would have enabled this team to prevent some of the more severe effects of the medical supply shortages since their experts talked about these shortages from way back in January.
Inadequate Information Systems
A lot can be said about the inadequacy of the SNS’s information systems, but two examples will suffice. First, its data management system hasn’t been upgraded from 2004 from the time the agency was created. With the speed at which technology is changing, a 2004 information management system is obsolete!
The second example is that SNS staff have been seen using their smartphones to take pictures as evidence of supplies that they have received or dispatched. You can’t track critical supplies using just a photo, and it is therefore not surprising that badly needed medical supplies are in short supply across the country.
In short, the agency cannot “see” where supplies exist and where they are running out, so they can’t play their strategic supplies management role.
Crucial Expertise is Lacking
The job of tracking strategically needed medical supplies isn’t one that can be given to any person. Special expertise is needed. For example, the SNS lacks analysts to track the different supply chains of supplies that are deemed critical. If such an expert existed, the agency would have known that Wuhan, China is the major source of PPE and since it was the epicenter of the coronavirus outbreak, the world couldn’t expect to source its PPE from such a location. Alternative sourcing would have been quickly mobilized to save the U.S. from the shortages it has seen during this crisis.
Americans and biomedical entities like Predictive Oncology (NASDAQ: POAI) are left with a question: what is the way forward? Experts advise the federal government to look at the Department of Defense’s diverse teams that work under an apex leadership team to brief all related departments about any developments being tracked. If the SNS is given the clout and support it deserves together with the needed organizational restructuring, any future pandemic isn’t likely to hit the U.S. as badly as the COVID-19 crisis has.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Net Element (NASDAQ: NETE) has recently transformed its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc. The company is set to begin marketing its initial vehicle model – the Dragonfly K50 – in 2Q2021. Developed in conjunction with China’s Qiantu Motors, the car model will mark Net Element’s initial foray into the North American electric vehicle market. The venture will be further reinforced through the launch of the Mullen MX-5, the company’s self-manufactured EV SUV, by the second quarter of 2022. An article discussing opportune timing of the move reads, “In an extensive report centered around the battery electric vehicles segment, Deloitte recently forecast that the electric vehicle market is set to reach a tipping point in 2022 . . . a point of time at which the consultancy expects the cost of ownership for a battery-powered vehicle to be on par with its internal combustion engine-powered counterparts, thereby reducing relative cost differences as a barrier to purchase. With that in mind, it is noteworthy to explore the potential target market size for Net Element as it makes its initial foray into the global EV marketplace (https://ibn.fm/yTFRm).”
Net Element operates a payments-as-a-service transactional and value-added services platform for small to medium enterprise (“SME”) in the United States and selected emerging markets. In the U.S., the company aims to grow transactional revenue by innovating SME productivity services using blockchain technology solutions and Aptito, its cloud-based, restaurant and retail point-of-sale solution. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500(TM). In 2017 Net Element was recognized by “South Florida Business Journal” as one of 2016’s fastest-growing technology companies. Further information is available at www.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
Rritual Mushrooms Inc. is an emerging producer of premium plant-based superfood products designed to help people meet the demands of modern life with style and ease
The company introduced the wellness and nutraceuticals market to its suite of three mushroom and adaptogen-based elixir powders in September
Rritual Mushrooms’ products were created to boost immunity, support brain function and help the body fight anxiety
Rritual is positioned to take advantage of lifestyle trends that have promoted plant-based proteins and reduced meat consumption in recent years, as well as an invigorated interest in immunity-enhancing substances brought on by the worldwide COVID-19 pandemic
Modern lifestyle natural wellness innovator Rritual Mushrooms is growing into a wellness wonder at the heart of a fledgling industry rife with opportunity.
Market analysts at Grand View Research, Inc. reported last year that the overall functional foods market size is projected to reach $275.77 billion by 2025, expanding at a CAGR of 7.9 percent between 2019 and 2025 (https://nnw.fm/NO6n2). The demand for nutraceuticals and functional foods is now expected to surge even more than anticipated last year, in part as a response to consumers’ efforts to incorporate more immunity-boosting supplements into their diets as a result of the COVID-19 pandemic, building on an already extant decline in the consumption of meat products as plant-based proteins have gained favor, according to the report.
Functional mushrooms as a segment of that marketplace is new enough that there is no dominant brand in place to lead the category. Rritual Mushrooms has completed development of a suite of premium functional mushroom and adaptogenic elixir powders that were developed by a leading team of scientists, doctors and experts across the wellness industry. The company is exploring an opportunity with an IPO as well.
The initial product line of non-psychoactive wellness elixirs includes a Chaga blend designed to boost immunity, a Lion’s Mane blend designed to support cognitive function and brain health, and a Reishi blend to help the body fight anxiety.
Chaga is found most commonly in birch forests of the Northern Hemisphere (https://nnw.fm/2MBDO) and Rritual’s blend pairs it with the adaptogen Eleuthero root (https://nnw.fm/wtc4L) for a product full of bioactive polysaccharides. Adaptogens are natural substances used in herbal remedies because they are thought to increase the resistance of organisms to biological stress (https://nnw.fm/0DCkY).
The Lion’s Mane mushroom is native to North America, Europe and Asia (https://nnw.fm/qMxa6) and Rritual’s blend pairs it with the adaptogen Rhodiola root (https://nnw.fm/5QtuG). The Reishi mushroom is used in traditional Chinese medicine and has been referred to for thousands of years as the mushroom of immortality (https://nnw.fm/qx70X). Rritual infuses it with the adaptogen Ashwagandha root (https://nnw.fm/c14go) for a combination rich in polysaccharides, triterpenes, amino acids and fatty acids that may improve quality of sleep for restless minds.
“The health and wellness benefits of mushrooms and plant-based therapies are backed by decades of scientific research. Rritual’s new line of elixirs embraces that research and provides consumers with an easy way to get a daily dose of the powerful effects,” Rritual President Dr. Mike Hart stated in a September news release announcing the new elixir powder product lines (https://nnw.fm/9UBDg).
The three formulations will be available in 14-stick packs and in 150-gram containers during the fall, and there will also be a 14-day variety pack that includes all three elixirs. They will be marketed through Rritual’s website and the company’s Amazon store initially, but the company expects to add outlets by building on its team connections with specialty e-commerce channels such as Costco, CVS, Walmart and Vitacost.
The company similarly anticipates building to a brick-and-mortar rollout of its products through team connections with retail outlets such as Wegmans, Fresh Thyme, Whole Foods, Shaw’s, Stop & Shop, Vitamin Shoppe, Target and Kroger submarket Ralphs and Harris Teeter stores.
NOTE TO INVESTORS: The latest news and updates relating to Rritual Mushrooms are available in the company’s newsroom at https://nnw.fm/Rritual
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
The company’s patent portfolio includes its own intellectual property and exclusive worldwide licenses, including in the U.S., Canada, Europe, Australia, Hong Kong, and China
180 Life Sciences is in the final stages of its merger process with KBL Merger Corp. IV, with the resulting entity to list on NASDAQ under the ticker “ATNF”
The company is devoting its clinical-stage biotechnology research to producing solutions that will help battle inflammation. Its primary focus is to treat fibrosis and inflammation using anti-TNF therapy
The estimated annual market size for anti-inflammatory therapeutics is projected to grow to an estimated $106.1 billion in 2020.
KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp. Rights NASDAQ: KBLMR) (KBL Merger Corp. Warrant NASDAQ: KBLMW), a Special Purpose Acquisition Corporation (SPAC) that has signed a detailed merger agreement with 180 Life Sciences Corp., announced that the company has continued to expand its IP portfolio. 180 Life Sciences Corp. is a clinical-stage biotech company currently in the developmental stage of three novel drugs. These drugs will fulfill the unmet need within the healthcare industry for inflammatory diseases, pain, and fibrosis.
The current patent portfolio that 180 Life Sciences Corp. has applied and received licenses for covers 14 patent families consisting of 42 patents issued and 32 pending in jurisdictions such as the United States, Europe, Canada, Japan, Australia, and China (https://nnw.fm/AMNwy).
The latest patent, granted on June 3 by the EU Patent and Trademark Office, is for methods of prevention or treatment of triggered inflammatory reactions using TNF alpha antagonist. “The issuance of our European patents significantly strengthens the IP portfolio governing our lead program,” 180 Life Sciences Corp. CEO Dr. James Woody said in the IP portfolio announcement.
“We are committed to broadening our global patent estate as we continue to expand our internal pipeline and increase patient access to innovative therapies,” Woody added. “Having this most recent patent awarded in the EU is important as it provides validation in the 12 largest countries in the EU, including the UK, and provides the platform to be able to expand clinical trials, commercialization, and partnering efforts throughout Europe. We look forward to achieving additional milestones by the end of 2020.”
On June 2, the company was granted a U.S. patent for the treatment of Dupuytren’s Disease, while on January 14, China granted a patent for synthetic CBD analog (“SCA”): cyclohexenyl compounds, compositions comprising them and uses. In addition, the company filed a patent for SCA bioactive phenolate ionic complexes in the U.S. on April 22 and one for method treating systemic fibrosis disorders using IL-33/TNF specific antibody, in Hong Kong on September 1.
The company’s patent portfolio comprises its own IP and exclusive worldwide licenses, including the Hebrew University, The Kennedy Trust for Rheumatology Research University of Oxford, Oxford University Innovation Limited, and Stanford University.
180 Life Sciences is currently conducting three clinical programs to address the following indications:
A Phase 2b/3 trial on Dupuytren’s contracture, a fibroid disease of the hand, with expected results in Q1 2021
A clinical study to be initiated for frozen shoulder with a grant awarded by the National Institute of Health Research, UK
A current unmet need in the elderly population, especially those who undergo hip replacement – post-operative cognitive delirium disorder and dysfunction
In addition to the current clinical trials, 180 Life Sciences Corp. currently has preclinical discoveries focusing on developing unique, FDA-approved pharmaceutical-grade cannabinoids for arthritis treatment. It is also working with an a7nAChR program initially aimed at the treatment of ulcerative colitis after smoking cessation (https://nnw.fm/nPn2g).
These studies, along with its expanding IP portfolio, are helping the company position itself as a leader on the anti-inflammatory therapeutics market, which is expected to grow to an estimated $106.1 billion in 2020. The company’s merger with KBL Merger Corp. IV is also expected to strengthen its position, while also enabling it to go public.
An October 12, 2020 announcement by KBL Merger Corp. IV indicated that the Form S-4 that was filed with the SEC regarding the merger is now effective. The company has scheduled a Special Meeting of the Shareholders for October 26, 2020. Once the merger is complete, 180 Life Sciences Corp. will list on NASDAQ under the ticker symbol “ATFN.”
NOTE TO INVESTORS: The latest news and updates relating to 180 Life Sciences are available in the company’s newsroom at http://nnw.fm/180
About NetworkNewsWire
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Related Editorial
Compelling evidence of the therapeutic benefits of psychedelic drugs appears in multiple scientific studies. Several clinical trials are underway in the United States and worldwide to investigate the therapeutic effects of psilocybin, the active component in the fungi known colloquially as “magic mushrooms.” There is new hope for treating such debilitating disorders as depression, anxiety, post-traumatic stress disorder, anorexia, obsessive-compulsive disorder, and addiction. With more than $6.8 billion on the line by 2027, companies at the vanguard of the psychedelic therapeutic drug market could reap enormous benefits in the coming years. Some of these companies, such as Cybin Corp. (Cybin Profile), which focuses on drug development and unique delivery mechanisms, are targeting areas that have been particularly underserved in the past decade. Those areas encompass life-disrupting psychiatric and neurological conditions such as major depressive disorder (MDD), addictions, and other mental illnesses. A pioneer in the psychedelic sector, CYBIN is working toward becoming the first life sciences company to bring a psilocybin drug targeting MDD to market. A successful outcome could completely upend treatment protocols. The psychedelic space’s promise is perhaps best illustrated by the sector’s largest-ever private financing round of $80 million for Compass Pathways (NASDAQ: CMPS), the first psychedelic company to IPO on the NASDAQ. Not to be outdone, Mind Medicine Inc. (OTC: MMEDF) is following suit; the company applied for NASDAQ uplisting last month. In addition, Field Trip Health Ltd. (CSE: FTRP) started trading on the Canadian Securities Exchange (CSE) earlier this month.
Cybin is a mushroom life-science company advancing psychedelic and nutraceutical-based products. The company expects to launch psilocybin-based products in jurisdictions where the substance is not prohibited. Simultaneously, the company is structuring and supporting clinical studies across North America and other regions through strategic academic and institutional partnerships. For more information, visit www.Cybin.com.
NOTE TO INVESTORS: The latest news and updates relating to Cybin are available in the company’s newsroom at http://nnw.fm/Cybin
About NetworkNewsAudio
NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.
NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that it will hold a live Zoom video webcast to discuss its financial and operational results for the third quarter ended September 30, 2020. Results will be issued in a press release prior to the event. The webcast is set to take place at 4:30 p.m. Eastern Time on Thursday, October 29, 2020. Wrap Technologies’ management will host the live video webcast, followed by a question and answer period, which will be linked from Wrap’s investor relations website. Interested parties may register for the event at https://nnw.fm/7NQqa.
Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury by agencies in cities including Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, LaGrange, St. Cloud and Oak Ridge. For information about the company, please visit www.WrapTechnologies.com.
NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://nnw.fm/WRTC
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
TAMPA, FL, Oct. 15, 2020 – Trxade Group, Inc. ( MEDS ) an integrated drug procurement, delivery and healthcare platform, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, October 26, 2020.
Management will host a conference call on Monday, October 26, 2020, at 5:00 p.m. Eastern time to discuss Trxade Group’s third quarter 2020 financial results. The call will conclude with Q&A from participants. To participate, please use the following information:
Q3 2020 Conference Call and Webcast
Date: Monday, October 26, 2020
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13711397
Webcast: http://public.viavid.com/index.php?id=141748
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
A playback of the call will be available through November 26, 2020. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13711397. A webcast will also be available for 30 days on the IR section of the Trxade Group website or by clicking the webcast link above.
About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (Nasdaq: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of three synergistic operating platforms; (1) the Trxade B2B trading platform with around 11,800 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division and (3) the Bonum Health platform offering affordable telehealth services. For additional information, please visit us at www.trxade.com and www.bonumhealth.com .
Investor Relations: Lucas Zimmerman
Senior Vice President
MZ Group – MZ North America
(949) 259-4987 MEDS@mzgroup.us www.mzgroup.us
Thursday, October 15th, 2020UncategorizedComments Off on $MEDS to Report Third Quarter 2020 Results on Monday, October 26th at 5:00 p.m. Eastern Time
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announced that its wholly owned subsidiary, Mulch Manufacturing Inc., was awarded a one-year natural mulch supply contract with two additional one-year extensions with the city of Vero Beach, Florida. According to the update, the company secured the contract shortly after its receipt of a mulch contract from Circle K convenience store divisions. “We are pleased to be awarded this new government contract opportunity and it’s all thanks to our recently completed construction in the Waste Management facility in central Florida,” SGTM’s CEO and Director Tony Raynor said in the news release.
Sustainable Green Team, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division and collection sites, then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential, and commercial clients. For information regarding SGTM’s operations, expansion plans and production facilities, visit http://nnw.fm/3iVHn
NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://nnw.fm/SGTM
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Sigma Labs (NASDAQ: SGLB), a leading developer of in-process, quality-assurance software for the commercial 3D-printing industry, has scheduled a conference call to discuss its third-quarter 2020 results. The call is scheduled for Thursday, Oct. 22, 2020, at 4:30 p.m. ET. The call will be hosted by Sigma Labs president and CEO Mark Ruport and CFO Frank Orzechowski, and will include an overview of the company’s performance covering the period ending Sept. 30, 2020. The two company executives will also participate in a Q&A session during the call. Those interested in accessing the call can dial in five to ten minutes prior to the call starting to register with an operator. Numbers are 1-877-407-9039 (toll free) in the United States or 1-201-689-8470 internationally; the conference ID for the call is 13711743. Those interested may also watch the broadcast live at https://nnw.fm/v7mJG or via the investor relations section of the company’s website at www.sigmalabsinc.com. In addition, the conference call will be available for replay through Nov. 5, 2020.
Sigma Labs is a leading provider of quality-assurance software to the commercial 3D-metal printing industry under the PrintRite3D(R) brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D for 3D-metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies in real time during the manufacturing process and informs the production manager of quality issues. Sigma Labs’ software product is a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.SigmaLabsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Pressure BioSciences (OTCQB: PBIO), a developer of innovative solutions for the worldwide life science and other industries, recently achieved another milestone as it nears initial production of commercial systems expected to revolutionize the nanoemulsification process for a wide variety of sectors. The company’s proprietary, next-generation Ultra Shear Technology-based BaroShear K45 System is designed to create unique, high-quality nanoemulsions of otherwise poorly soluble oils in order to render them more easily absorbed and effective in the water-based biology of human bodies. Pressure BioSciences earlier this year announced the launch of its UST Demonstration Laboratory as a place to showcase the technology’s potential to process cannabidiol (“CBD”) oil into true, high-quality, water-soluble nanoemulsions. PBIO reached sold-out status for its initial rollout of 12 planned BaroShear K45 systems. Then, on Oct. 6, the company announced the lock-in of final design specifications for the BaroShear K45’s commercial production model, which immediately launched work on construction of the initial K45 Alpha unit. Upon final completion, testing and approval of the Alpha unit, PBIO will build an additional 14 units, 12 of which are earmarked as ready-for-sale systems in time for the company to fulfill plans for shipping them during early 2021. An article discussing this quotes Pressure BioSciences’ director of marketing and sales, Kenneth F. Micciche. “Our commercialization plan for the BaroShear K45 system is initially focused on the rapidly growing hemp-derived CBD market, which is projected to reach $20 billion by 2020,” Micciche stated in a recent update. “We plan to install these (12 BaroShear K45 nanoemulsification) systems during the first half of 2021, which we believe will generate up to $3 million in revenue. Once these initial units are installed and in commercial use, we believe they will propel the close of multiple sales of additional BaroShear K45 systems during the latter half of 2021 and thereafter.”
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life science and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure-cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control biomolecular interactions safely and reproducibly (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) recently acquired, patented technology from BaroFold Inc. (the BaroFold technology) to allow entry into the bio-pharma contract services sector, and (2) recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher-quality, homogenized, extended shelf-life or room-temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit www.PressureBioSciences.com.
NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://nnw.fm/PBIO
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Predictive Oncology (NASDAQ: POAI)’s Soluble Biotech division has finalized its first substantial contract with a pharmaceutical company since its acquisition by POAI earlier this year (https://ibn.fm/gXjd2). Soluble Biotech is a provider of stable and soluble formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. Under the contract, Soluble Biotech will provide its expertise in protein expression and solubility studies. A recent article discussing this quotes Soluble Biotech founder Dr. Larry DeLucas. “Our first contract is a major milestone and validates our recent move into a new, larger facility,” Dr. DeLucas stated. “We quadrupled our laboratory and office space, some of which will eventually include a GMP facility. Additionally, we acquired state-of-the-art equipment to support our fermentation, therapeutic protein formulation development and protein stability studies. With our first contract on the books, and expanded capacity, the future is bright. We are currently negotiating several additional contracts with biotechnology and pharmaceutical companies.”
Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Skyline Europe. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. Helomics’ CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions by providing an evidence-based road map for therapy. In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor(TM), patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary bioinformatics platform to provide a tailored solution to its clients’ specific needs. Predictive Oncology’s Skyline Medical division markets its patented and FDA-cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. The company has achieved sales in five of the seven continents through both direct sales and distributor partners. For more information, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
Net Element’s reverse merger with EV manufacturer Mullen Technologies expected to close by 4Q2020
Mullen expects to begin marketing Dragonfly K50, sold in conjunction with JV partner Qiantu Motors from 2Q2021 followed by its own EV SUV in 2022
Deloitte expects annual EV sales to rise from 2.5mn in 2020 to 31.1mn in 2030, implying 29% CAGR over next ten years
By 2030, EVs expected to account for 32% of all automobile sales globally, approximately 27% in United States
Net Element (NASDAQ: NETE), a financial technology company which has recently transformed its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc., is set to begin marketing its initial vehicle model – the Dragonfly K50 in 2Q2021. The car model, developed in conjunction with China’s Qiantu Motors, will mark Net Element’s initial foray into the North American electric vehicle market—a venture which the company will further reinforce through the launch of its self-manufactured EV SUV, the Mullen MX-5, by the second quarter of 2022.
In an extensive report centered around the battery electric vehicles segment, Deloitte recently forecast that the electric vehicle market is set to reach a tipping point in 2022 – a point of time at which the consultancy expects the cost of ownership for a battery-powered vehicle to be on par with its internal combustion engine-powered counterparts, thereby reducing relative cost differences as a barrier to purchase. With that in mind, it is noteworthy to explore the potential target market size for Net Element as it makes its initial foray into the global EV marketplace (https://ibn.fm/dVlgo).
By 2030, Deloitte anticipates that EV sales could rise from 2.5 million vehicles per annum in 2020 to 31.1 million vehicles per annum—implying a compounded annual growth rate of 29 percent over the next ten years. Moreover, they expect that electric vehicles will secure a market share of 32 percent of total automotive sales by 2030, with battery electric vehicles accounting for 81 percent (25.3 million units) of all new electric vehicles sales and the balance share made up of plug-in hybrid electric vehicles.
However, while electric vehicles are set to grow as a proportion of total automotive sales, their geographic distribution will vary significantly. Deloitte expects EVs to capture a domestic market share of around 48 percent within China by 2030 – almost double that of the United States (27 percent)—with EV sales in Europe accounting for 42 percent of total auto sales in that region.
There are four key factors identified by Deloitte as being key drivers in determining the adoption rate of electric vehicles going forward. First is the shift which is currently being witnessed within consumer sentiment – driving range, a perennial point of contention in the past, has increasingly become less of a concern for potential consumers, with EV driving ranges enjoying a considerable uplift in line with new battery technology breakthroughs. Rather, the primary constraint for future growth may relate to a perceived lack of charging infrastructure, an issue which governments worldwide are seeking to tackle. Germany has recently designated $2.8 billion towards EV charging infrastructure investment while China has recently announced an additional $378 million investment in the technology.
Second is the role of government policy, wherein the widespread adoption of EVs has become a necessary step for governments seeking to achieve their climate-change goals, such as those set by the 2015 Paris Agreement. As a result, a number of governments have offered compelling financial incentives to consumers to make the switch to electric vehicles with other governmental bodies imposing bans, or punitive taxes, on users of older internal-combustion engines to address concerns about toxic air pollution.
The third factor relates to the commercial strategies adopted by various automotive OEMs (original equipment manufacturers). Over the past year, a number of major automotive OEMs have committed to significant upfront investments in developing their EV portfolios, with the likes of Ford announcing that it would invest $11.5 billion on EV models by 2022 while the Volkswagen Group has forecast achieving 1 million EV sales by 2023. More importantly, a greater focus on EVs has led to a greater proliferation of choice available to consumers, with HIS Markit predicting that there will be 130 EV models available to US consumers by 2026, from 43 different automobile manufacturers (https://ibn.fm/esdoB).
Lastly, Deloitte has highlighted the importance of major corporations in helping EV sales transition into the mainstream with the consultancy previously revealing that the sale of new cars to businesses would account for 63 percent of total new car sales across Western Europe by 2021 (https://ibn.fm/qYCbJ).
With traditional company car schemes and car hire operators accounting for a significant proportion of the client wallet for automobile purchases, a greater emphasis on alleviating emissions could result in a significant uplift in EV demand across the corporate spectrum.
Following the completion of the merger between Net Element and Mullen Technologies, the company aims to reach a production threshold of 35,000 vehicles per annum by 2026. With its initial two models already in the works and with the global EV sector set to skyrocket in terms of value over the course of the next decade, Net Element finds itself in the ideal position to capitalize from one of the biggest shifts in consumer behavior the world has ever seen.
For more information, visit the company’s website at www.NetElement.com.
NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://ibn.fm/NETE
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
As society begins to accept that the current COVID-19 pandemic is going to be around for quite a while, mining companies have started paying more attention to e-learning for their managers and employees on matters of occupational safety and other pertinent issues. Several factors account for this increasing attention to online training.
Convenient
The ongoing pandemic has disrupted work shifts and even kept a number of mining sector workers at home, so it is difficult to organize face to face training sessions without violating social distancing protocols.
With e-learning, mining company employees can study anywhere, at any time and using any device of their choice. There has been no better time to upgrade the skills of employees in the mining sector!
More Engaging
Online training is usually interactive and this leads engagement levels to skyrocket. This is because team leaders and employees can use virtual reality and augmented reality to get a firsthand experience of the concepts they are learning.
For example, a mining company like Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) can simulate a mine accident so that employees appreciate the importance of conducting risk assessments before embarking on their day’s planned activities.
Consistency and Uniformity
Many mining companies have teams and active sites in diverse locations, and yet the training needs of the entire workforce could be the same. When digital learning is instituted, it becomes easy to standardize the training that all those employees receive because the online platform allows the training materials and methods to be uniform and consistent.
It is therefore easier to keep all staff at the same level of safety consciousness and technical ability for better outcomes.
More Affordable
If the current pandemic has taught companies anything, it is the painful realization that every penny counts. With cash reserves dwindling and the mining sector recovering at a slower pace than sector players would prefer, companies are turning to online training in order to keep costs minimal while sharpening the skills of their employees.
With e-learning, companies don’t have to fly trainers to different locations and venues don’t have to be booked for the training sessions. These lower costs have led mining companies to devote more attention to staff training since it doesn’t put such a dent in company finances and yet the benefits of such training are immense.
Adaptability
Online training materials can be tweaked quickly and easily in order to respond to the evolving needs of a mining company. For example, a company that discovers that several near-miss safety incidents are arising from their materials handling equipment can adjust the safety training to give more attention to the problem area which has been identified.
As the “new norm” with the coronavirus in our midst gets firmly entrenched, we are likely to see e-learning playing a more prominent role in the way mining companies conduct their business. The added benefit of this shift is that a lot more mining-related activities could be taken online.
About MiningNewsWire
MiningNewsWire (MNW) is a specialized communications platform focused on developments and opportunities in the global resources sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, MNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MNW brings its clients unparalleled visibility, recognition and brand awareness. MNW is where news, content and information converge.
To receive SMS text alerts from MiningNewsWire, text “BigHole” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the MiningNewsWire website applicable to all content provided by MNW, wherever published or re-published: https://www.MiningNewsWire.com/Disclaimer
People who suffer from depression usually report that they feel so fatigued that even mundane tasks, such as leaving their beds, are very difficult to manage. According to research, approximately 90% of all the people with major depressive disorder suffer from fatigue. Here are some of the reasons why you may feel fatigued if you suffer from depression.
Sleep Problems
Sleep is essential because it allows the body to replenish its energy supplies and to recover from any damage sustained during the waking hours. If you are depressed, you are likely to have difficulties falling asleep or even staying asleep. This sleep deprivation means that your energy reserves aren’t being replenished as they should, and that accounts for the tiredness you feel.
Other sleep problems, such as obstructive sleep apnea and hypersomnia (constantly feeling sleepy), also increase fatigue.
Your Diet
A meta study done in 2018 found some evidence that a diet which is rich in inflammation-causing foods, such as processed meats, increased one’s likelihood for developing depression and the fatigue associated with those poor dietary choices.
Furthermore, people who are depressed often lack the motivation to be mindful when choosing what to eat, and this increases the odds that they will select foods which aren’t healthy. Such foods will increase the fatigue that the person feels.
Stress
Stress wreaks havoc one’s dopamine and serotonin levels and yet these neurotransmitters play a major role in determining your energy levels and mood. Since chronic stress is usually behind the onset of depression, it is therefore not surprising that when you are depressed, you will feel fatigued all the time.
Research also shows that stress can trigger inflammation in different parts of the body, and that inflammation will sap your energy and leave you feeling fatigued.
Some Medications
Antidepressants help the neurotransmitters in the brain to be more effective at regulating your mood, and therefore alleviate depression. However, some antidepressants have the side effect of making a patient to feel fatigued, and that may explain why you may be feeling tired all the time yet you are taking your medication to combat depression.
There are different coping mechanisms which can help if you are constantly depressed and tired, but perhaps the most important one, which biomedical companies like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) would be likely to recommend, is for you to talk to an experienced doctor. This professional will assess you before designing an intervention protocol to help you get better. For example, they may prescribe different medication if what you are currently taking is causing you to feel tired all the time.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
HONG KONG , Oct. 15, 2020 — iClick Interactive Asia Group Limited (“iClick” or the “Company”) (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China today unveiled its new “Chinese Travel Shoppers White Paper 2020” in association with The Moodie Davitt Report and ClickInsights to present the latest Chinese market trends and the travel retail outlook for 2020.
The White Paper was unveiled during the Moodie Davitt Virtual Travel Retail Expo this week, a unique and pioneering virtual travel trade show and symposium that has been designed to both mirror and improve upon a traditional conference and exhibition complete with networking, meeting facilities and workshops by global travel retail industry leaders. To find out more about this unique event, please click on the following link https://virtualtrexpo.com/about-expo/ .
iClick’s Whitepaper on Chinese Travel Shoppers 2020 provides high-level intelligence on three key travel groups – Families Trip travelers with sufficient money but not sufficient time, New Package Tour travelers with sufficient money and time, and Youthful Characteristics travelers who lack sufficient money but have sufficient time — and recommended approaches to fulfill the demands of these three travel groups. This intelligence is based on analysis provided by iClick’s proprietary iAudience platform that covers more than 940 million Chinese consumers, including 98.7% of Chinese netizens. According to the China National Bureau of Statistics, there is huge potential for Chinese outbound travelers – 169 million in 2019 [1] , more than 12% of the annual international tourist arrivals– and it expects a solid rebound in 2021 despite the COVID-19 impact, estimating to hit 300 million outbound travelers by 2027 [2] .
“The outbreak of the novel coronavirus has challenged the global travel industry in unprecedented ways this year,” said Frankie Ho , President of International Business at iClick. “It is business unusual, and huge challenges and uncertainties are overshadowing the travel retail outlook for 2020. iClick has had experience working with many leading travel retail brands to reach and deliver their messages to Chinese travel shoppers trotting across the globe over the past years. Our new whitepaper leverages iClick’s proprietary iAudience market intelligence platform to reveal trends about this highly sought-after consumer segment. Not only does the whitepaper challenge the market segmentation that has been traditionally used, but it also identifies some future trends and reveals implications for marketers of related industries.”
Martin Moodie , Founder and Chairman of The Moodie Davitt Report, said “The COVID-19 crisis has had a profound impact on the aviation, tourism and travel retail sectors and will continue to reshape the industry going forward. Facing dramatically reduced passenger density, even once 2019 levels are restored the travel retail channel will still face an overwhelming need to encourage more frequent travel. Going beyond tourism and spending numbers and projections to examine consumer dynamics, varying customer profiles, and key behavioural components, including travel and shopping trends, iClick’s new whitepaper will help achieve this goal by helping travel retail players better understand today’s travel consumers. The Moodie Davitt Report is proud to be associated with this study which will help guide the industry to a more prosperous future.”
iClick Interactive Asia Group Limited (NASDAQ: ICLK) is an independent online marketing and enterprise data solutions provider that connects worldwide marketers with audiences in China . Built on cutting-edge technologies, our proprietary platform possesses omni-channel marketing capabilities and fulfils various marketing objectives in a data-driven and automated manner, helping both international and domestic marketers reach their target audiences in China. Headquartered in Hong Kong , iClick was established in 2009 and is currently operating in ten locations worldwide including Asia and Europe .
For more information, please visit ir.i-click.com .
About The Moodie Davitt Report
The Moodie Davitt Report, founded by Martin Moodie , is published by independent UK company Moodie International, one of the world’s most successful multi-media business-to-business publishers and event organisers. The website was launched as The Moodie Report in March 2003 and quickly became established as an indispensable source of reliable and real-time business intelligence on the global travel retail sector. It now attracts over 500,000 page views a month. The company also owns and organises (with Airports Council International) The Trinity Forum – the most influential airport commercial revenues conference – and The Airport Food & Beverage (FAB) Conference & Awards. In October 2020 it launched the Moodie Davitt Virtual Travel Retail Expo, the sector’s first-ever virtual exhibition and conference.
Safe Harbor Statement
This announcement contains forward-looking statements, including those related to the Company’s business strategies, operations and financial performance. These statements constitute “forward-looking” statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident” and similar statements. Such statements are based upon management’s current expectations and current market and operating conditions and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: the Company’s fluctuations in growth; its success in implementing its mobile and new retail strategies, including extending its solutions beyond its core online marketing business; its success in structuring a CRM & Marketing Cloud platform; relative percentage of its gross billing recognized as revenue under the gross and net models; its ability to retain existing clients or attract new ones; its ability to retain content distribution channels and negotiate favorable contractual terms; market competition, including from independent online marketing technology platforms as well as large and well-established internet companies; market acceptance of online marketing technology solutions and enterprise solutions; effectiveness of its algorithms and data engines; its ability to collect and use data from various sources; ability to integrate and realize synergies from acquisitions, investments or strategic partnership; fluctuations in foreign exchange rates; and general economic conditions in China and other jurisdictions where the Company operates; and the regulatory landscape in China and other jurisdictions where the Company operates. Further information regarding these and other risks is included in the Company’s annual report on Form 20-F and other filings with the SEC. All information provided in this press release and in the attachments is as of the date of this press release, and the Company undertakes no obligation to update any forward-looking statement, except as required under applicable law.
SOUTH SAN FRANCISCO, Calif. , Oct. 14, 2020 — VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (CNS) disorders, today announced that the Company received written notification from the Listing Qualification Department of The NASDAQ Capital Market (“Nasdaq”) granting the Company’s request for a 180-day extension to regain compliance with Nasdaq’s minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”). The Company now has until April 12, 2021 to meet the requirement.
“We are pleased that Nasdaq granted our request for an extension,” said Shawn K. Singh , VistaGen’s CEO . “We believe we will regain compliance during the extended time period as we continue to advance the three differentiated drug candidates in our CNS pipeline, a pipeline with exciting potential to go beyond the current standard of care for multiple anxiety and depression disorders, as well as several neurological conditions.”
Nasdaq’s extension notice has no immediate effect on the continued listing status of the Company’s Common Stock on the Nasdaq Capital Market. Therefore, the Company’s listing remains fully effective.
For more information, please review the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 13, 2020 .
About VistaGen VistaGen Therapeutics is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets. For more information, please visit www.vistagen.com and connect with VistaGen on Twitter , LinkedIn and Facebook .
Forward Looking Statements
Various statements in this release are “forward-looking statements” concerning VistaGen’s future expectations, plans and prospects. These forward-looking statements are neither promises nor guarantees of future performance, and are subject to a variety of risks and uncertainties which could cause actual results to differ materially from those contemplated in these forward-looking statements, including the risks that: the Company may not regain compliance with the Rule during the 180-day extension period granted by Nasdaq; development and approval of one or more of the Company’s drug candidates may not be achieved in any market, and, if approved, may not be differentiated from the standard of care; the FDA and other regulatory authorities may decide that the results of one or more of the Company’s development programs are not sufficient for regulatory approval; development of the Company’s drug candidates may not be successful in any indication; success in nonclinical studies or in earlier-stage clinical studies may not be repeated or observed in future studies; and other adverse events or market conditions may be encountered, at any stage of development, that negatively impact further development, including entry of competitive products or other technical and unexpected hurdles in the development, manufacture and commercialization of the Company’s drug candidates. Additional risks are more fully discussed in the section entitled “Risk Factors” in VistaGen’s most recent Annual Report on Form 10-K for the year ended March 31, 2020 , and in its subsequent quarterly report on Form 10-Q, as well as discussions of potential risks, uncertainties, and other important factors in the Company’s other filings with the Securities and Exchange Commission. Any forward-looking statements represent the Company’s views only as of today and should not be relied upon as representing its views as of any subsequent date. The Company explicitly disclaims any obligation to update any forward-looking statements.
Wednesday, October 14th, 2020UncategorizedComments Off on $VTGN Nasdaq Grants VistaGen 180-Day Extension to Meet Minimum Bid Price Requirement
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its new 2-liter six-pack packaging for its flagship brand, Alkaline88(R), will now be carried by HomeGoods stores across 500 nationwide locations. “We are excited to announce that our new 2-liter six-pack offering for our core brand, Alkaline88, will be available at HomeGoods stores nationwide,” WTER president and CEO Ricky Wright said in the press release. “This unique six-pack complements our existing line-up, especially our single-serve offerings, which continue to do well in the current environment. The two-liter format is extremely popular in the carbonated soft drinks segment but virtually nonexistent in the bottled water category. Originally we envisioned this format for the club market, but we see this resonating with the health and wellness lifestyle-focused consumers across all trades given its optimal size. We believe this packaging will appeal to buyers that tend to make purchases in larger quantities and fills the void that currently exists in the club market as well as specialty retailers.”
Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in seven unique all-natural flavors with new flavors coming soon. Additionally, in 2020, the company launched A88 Infused Beverage Division Inc., which includes the company’s CBD water and flavor-infused water. For the company’s topical and ingestible offerings, A88 Infused Products includes both the company’s lab-tested, full-spectrum hemp salves, balms, lotions, essential oils and bath salts, along with broad-spectrum hemp beverage shots, powder packs, oil tinctures, capsules and gummies. To learn more about the company, visit www.A88CBD.com and www.TheAlkalineWaterCo.com.
NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://cnw.fm/WTER
About CannabisNewsWire
CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer
Do you have questions or are you interested in working with CNW? Ask our Editor
By now, you must have heard that hand washing, social distancing, wearing face masks and using a hand sanitizer are valuable tools in the fight against SARS-Cov-2 infection. It now turns out that using a dental mouthwash could also be an additional way to prevent the replication of the coronavirus once it gets into your mouth and throat.
Before you dismiss this suggestion as a wild idea, consider the fact that it was made by none other than the widely respected American Physiological Society. This society was established in 1887 and it brings together all biomedical professionals whose specialty is studying how cells, molecules, tissues and organs function in relation to health and disease. The group publishes 16 peer-reviewed journals whose readership is spread out across the globe.
In their recent evidence review article which appeared in the journal Function, the APS suggests that readily available dental mouthwashes have the capacity to destroy the lipid envelop of different coronaviruses. This destruction would prevent those viruses from replicating in the mouth and throat, thereby averting a likely infection before it takes root.
It should be noted that coronaviruses obtain their lipid envelop from the cells on which they bud (the cells of the host), and this envelop easily succumbs to bio-membrane disruptors.
The authors write that current research shows that the salivary glands and the throat play an important role in the replication and transmission of SARS-Cov-2 viruses. However, while the lipid membrane of these viruses can be easily destroyed, not a lot of research has been done to establish how that can be achieved.
The team suggests that attacking the lipid membrane is easy and even if the coronaviruses mutate, they will still remain vulnerable to the destruction of their lipid envelop.
The APS team also reviewed different ingredients found in approved dental mouthwash products. Those ingredients that could destroy the lipid membrane of the coronaviruses include hydrogen peroxide, ethanol, povidone-iodine, chlorhexidine and so many others.
The review team concludes that several of the mouthwash formulations have so much potential that they deserve to be subjected to clinical studies to evaluate to what extent they would be helpful in destroying the lipid envelop of coronaviruses, and thereby slowing the spread of SARS-Cov-2.
This is an interesting suggestion that could intrigue biomedical sector players like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) who would probably be interested in seeing low-cost solutions of stemming the spread of the ongoing pandemic available to the most vulnerable populations around the world.
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
SRAX (NASDAQ: SRAX), an innovative fintech solutions provider, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to provide specialized content distribution via widespread syndication channels. The episode features Christopher Miglino, founder and CEO of SRAX, and Chris Lahiji, president of LD Micro. During the program, the two executives discuss the recent acquisition of LD Micro, a leading data and event company serving the small and micro-cap space, by SRAX, a financial technology company that unlocks data and insights for publicly traded companies through its SaaS platform, Sequire. SRAX announced closing of the acquisition on Sept. 16, 2020, noting that LD Micro will operate as a wholly owned subsidiary of SRAX and will continue to employ Lahiji, its founder, as its president. “If you look at what we’ve built at LD, we’ve had a lot of interest over the last 11 or 12 years in getting acquired, but the reality was that every single organization wanted to use the community that we had built for the wrong purposes,” Lahiji stated in the interview. “Christopher Miglino was the only guy who came to me and essentially asked the right questions and found a way of taking what we had built since 2002 and enhancing it. . . . With SRAX, I have the ability to increase my reach by more than 100-fold without having to sacrifice anything that has been built prior to [the acquisition]. The dynamics that they bring to the table for LD are incalculable.”
SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information about the company, visit www.SRAX.com.
NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Sigma Labs (NASDAQ: SGLB), a leading developer of in-process quality assurance software for the commercial 3D metal printing industry, today announced its partnership with IN4.OS, a leader in advanced manufacturing. Under the collaboration, the partners will build “Smart Factories of the Future” to meet the demands of high technology sectors including defense, space, aerospace and life sciences. An IN4.OS US LLC concept, a Smart Factory of the Future is a cyber-physical system, location agnostic factory that has the ability to deliver flexible and scalable manufacturing capabilities. The design will integrate Sigma Labs’ PrintRite3D(R) technology to ensure the highest level of quality for mission-critical metal parts manufactured with 3D printers. In addition, IN4.OS will utilize DMG MORI’s LASERTEC line of 3D metal printers, which have been designated as PrintRite3D Ready. “IN4.OS’s concept of Smart Factories of the Future is a timely and courageous response to increasing the country’s self-sufficiency in times when supply chains are disrupted,” SGLB president and CEO Mark K. Ruport said in the news release. “We are excited to work with IN4.OS and DMG MORI, as they take on this important initiative.”
Sigma Labs is a leading provider of quality assurance software to the commercial 3D metal printing industry under the PrintRite3D(R) brand. Sigma specializes in the development and commercialization of real-time monitoring solutions known as PrintRite3D for 3D metal advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process and informs the production manager of quality issues. Sigma Labs believes its software product will be a major catalyst for the acceleration and adoption of 3D metal printing. For more information, please visit www.SigmaLabsInc.com.
NOTE TO INVESTORS: The latest news and updates relating to SGLB are available in the company’s newsroom at http://nnw.fm/SGLB
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, has announced that it will sponsor this week’s 2020 Protecting New York Summit. The virtual event, scheduled for Thursday, Oct. 15, 2020, provides an opportunity for industry executives, public sector leaders and academics to share ideas about New York’s security strategy. The event agenda includes topics ranging community policing to keeping New Yorkers safe during the pandemic. In addition to its sponsorship, Wrap Technologies will have a participant in the summit. WRTC president Tom Smith is a featured panel member on a panel that will discuss New York’s public safety concerns, particularly the instability that has resulted from the pandemic, social unrest and the economic downturn. The panel includes industry, community and policy makers. “Wrap Technologies is delighted to sponsor and participate in the Protecting New York Summit,” said Smith in the press release. “Our mission is to create advanced technologies for the safety and security of public safety. Wrap is working to close a critical gap that exists in policing by offering the BolaWrap(r) Remote Restraint device to benefit not just law enforcement officers but also all of us. We are proud to sponsor this event and share our insight and solutions.”
Wrap Technologies is an innovator of modern policing solutions. The company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R)tether to restrain an individual at a distance from 10 to 25 feet. Developed by award-winning inventor Elwood Norris, the company’s chief technology officer, the small but powerful BolaWrap 100 assists law enforcement in safely and effectively deescalating encounters, especially those involving an individual in crisis. BolaWrap 100 has already been used to safely apprehend suspects without injury in Los Angeles, Sacramento, Fresno, Bell, Albuquerque, Minneapolis, West Palm Beach, Fort Worth, LaGrange, St. Cloud and Oak Ridge. For information about the company, visit www.WrapTechnologies.com.
NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://nnw.fm/WRTC
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
The past decade or so has been pivotal for the auto vehicle industry. The emergence and increasing popularity of automakers like Tesla who only produce electric vehicles (“EVs”) has inspired most automakers to add electric vehicles to their roster of vehicles. This comes at a time when most developed governments are becoming increasingly conscious of pollution and climate change and are taking steps to reduce their carbon footprints.
According to a UK company, not only are EVs energy efficient and produce zero emissions, but they are generally cheaper to run and maintain than diesel or petrol cars. After crunching the numbers, Direct Line found that on average, an electric vehicle is £107 ($139.62) cheaper a year to own than a conventional internal combustion-powered car. The average lifetime running costs for an electric vehicle, including purchase price, is £52,133 ($68,025.75), while an equivalent petrol-powered model will cost you £53,625 ($69,972.58) over its lifetime.
An electric car owner would have to shell out £3,752 ($4,895.80) per year to keep their vehicle running compared to a traditional internal combustion-powered vehicle which costs £3,858 ($5034.11) per year. Thus, an EV owner will save £107 ($139.62) annually, adding up to around £1,070 ($1,396.19) – £1,605 ($2,094.28) over the course of 10-15 years.
This is despite the fact that electric vehicles on average cost £5,000 or 22% more than internal combustion-powered vehicles, even when the Government’s Plug-in Car grant which provides £3,000 subsidies for sub-£50,000 zero-emission cars is considered. Once the initial costs such as purchasing and installing a home charger are covered, Direct Line calculated that an EV owner will spend only £33.50 ($43.71) per week to keep their vehicle running. This is 21% cheaper than the £42.40 ($55.2) per week it would cost to keep a conventional gas-powered vehicle running.
Additionally, the annual tax and maintenance costs (including MOTs and servicing) for electric vehicles are 49% lower than for gas-powered models. It will also cost EV drivers 58% less to refuel (charge) the vehicle. However, due to “current production costs and complexities involved in the calibration of computers used in these cars,” Direct Line says, the insurance costs for EVs are, on average, 25% higher compared to traditional vehicles.
In its research, Direct Line also found that electric cars hold their value better than their gas-powered equivalents, with a year old EV losing only 12% of its value compared to a year old gas-powered vehicle which loses 24% of its value.
This research goes to prove why entities like Net Element (NASDAQ: NETE) believe so strongly that electric vehicles are the future.
About Green Car Stocks
Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.
To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer
